Ginsenoside Rh2 inhibits vascular endothelial growth factor-induced corneal neovascularization

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
Xiao-Pei ZhangCong Cao

Abstract

VEGF-induced neovascularization plays a pivotal role in corneal neovascularization (CoNV). The current study investigated the potential effect of ginsenoside Rh2 (GRh2) on neovascularization. In HUVECs, pretreatment with GRh2 largely attenuated VEGF-induced cell proliferation, migration, and vessel-like tube formation in vitro. At the molecular level, GRh2 disrupted VEGF-induced VEGF receptor 2 (VEGFR2)-Grb-2-associated binder 1 (Gab1) association in HUVECs, causing inactivation of downstream AKT and ERK signaling. Gab1 knockdown (by targeted short hairpin RNA) similarly inhibited HUVEC proliferation and migration. Notably, GRh2 was ineffective against VEGF in Gab1-silenced HUVECs. In a mouse cornea alkali burn model, GRh2 eyedrops inhibited alkali-induced neovascularization and inflammatory cell infiltrations in the cornea. Furthermore, alkali-induced corneal expression of mRNAs/long noncoding RNAs in cornea were largely attenuated by GRh2. Overall, GRh2 inhibits VEGF-induced angiogenic effect via inhibiting VEGFR2-Gab1 signaling in vitro. It also alleviates angiogenic and inflammatory responses in alkali burn-treated mouse corneas.-Zhang, X.-P., Li, K.-R., Yu, Q., Yao, M.-D., Ge, H.-M., Li, X.-M., Jiang, Q., Yao, J., Cao, C. ...Continue Reading

References

Sep 17, 1998·Japanese Journal of Cancer Research : Gann·H NakataN Shinomiya
Aug 17, 2001·Current Opinion in Ophthalmology·J H ChangD T Azar
Jul 13, 2002·Trends in Molecular Medicine·Noël Bouck
Jun 5, 2003·Nature Medicine·Napoleone FerraraJennifer LeCouter
Nov 6, 2003·Biological & Pharmaceutical Bulletin·Eun-Kyung ParkDong-Hyun Kim
Mar 3, 2004·Biological & Pharmaceutical Bulletin·Eun-Kyung ParkDong-Hyun Kim
Apr 28, 2005·The American Journal of Pathology·Shizuya SaikaAnita B Roberts
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Sep 6, 2008·Advances in Food and Nutrition Research·Lars P Christensen
Aug 26, 2009·Recent Patents on Inflammation & Allergy Drug Discovery·Yadollah ShakibaNima Rezaei
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Yao LuJincai Luo
Oct 4, 2012·Nano Letters·Chia-Hsuan WuJohn Marshall
Feb 21, 2013·PLoS Biology·Cong CaoJohn Marshall
Mar 14, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Li-Hua LianJi-Xing Nan
Jan 18, 2014·Investigative Ophthalmology & Visual Science·Biao YanQin Jiang
Aug 1, 2014·The Journal of Investigative Dermatology·Yi-Ming ZhangCong Cao
Jan 13, 2015·Investigative Ophthalmology & Visual Science·Ming Wai PoonQizhou Lian
Jan 20, 2016·Scientific Reports·Zhiqing YangLeida Zhang
Mar 17, 2016·Translational Vision Science & Technology·Napoleone Ferrara
May 15, 2016·Acta Biochimica Et Biophysica Sinica·Jingjia HuangZhiyong Luo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.